Clinical Trial Update: AZD0530 and Gemcitabine in Locally Advanced/Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating AZD0530 with gemcitabine in locally advanced or metastatic pancreatic cancer that is unresectable.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• AZD0530 (saracatinib)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED